This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sangamo Therapeutics, Inc., University of Southern California. Active years: 2020.
Company Filing History:
1 out of 153 
1 out of 1,693 
Years Active: 2020
Title: Colin Michael Exline: Innovator in Genome Engineering
Introduction
Colin Michael Exline is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of genome engineering, particularly through his innovative patent.
Latest Patents
Colin holds a patent titled "Delivery methods and compositions for nuclease-mediated genome engineering." This patent discloses methods and compositions for the delivery of engineered nucleases and donor molecules into the genome of a cell. His work in this area is crucial for advancing genetic engineering techniques.
Career Highlights
Colin has worked with prominent organizations such as Sangamo Therapeutics, Inc. and the University of Southern California. His experience in these institutions has allowed him to develop and refine his expertise in genome engineering.
Collaborations
Colin has collaborated with esteemed colleagues, including Paula M. Cannon and Michael C. Holmes. These partnerships have further enriched his research and contributions to the field.
Conclusion
Colin Michael Exline is a pioneering inventor whose work in genome engineering continues to influence the scientific community. His patent and collaborations highlight his commitment to advancing genetic research and technology.